Keywords: Alzheimer's Disease, Brain, Amnestic mild cognitive impairment; hippocampus; MEGA-PRESS; amide proton transfer-weighted imaging; imaging diagnostic markerAmnestic mild cognitive impairment (aMCI) is considered as a prodromal stage of Alzheimer's disease (AD). Growing evidence supports the hypothesis that unbalanced excitatory/inhibitory (glutamate and gamma-aminobutyric acid) neurotransmitters and consequent abnormal protein deposition in hippocampus contribute to the pathological process of MCI and AD. We explored the changes of hippocampal Glx/GABA+ levels and APTw in aMCI patients using MEGA-PRESS and APTw imaging. Patients with aMCI exhibited decreased Glx levels (and Glx/GABA+ ratios) and increased APTw values in hippocampus. The combination of Glx and APTw values improved the diagnostic performance for aMCI, suggesting it was a potential imaging diagnostic marker.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords